Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating expenses:
Research and development	$ 5,226	$ 4,381
General and administrative	5,424	5,519
Total operating expenses	10,650	9,900
Operating loss	(10,650)	(9,900)
Other income:
Interest income (expense), net	151	3
Other income	9	2
Interest and other income, net	160	5
Net loss	$ (10,490)	$ (9,895)
Net loss per share, basic	$ (6.83)	$ (7.48)
Net loss per share, diluted	$ (6.83)	$ (7.48)
Weighted average number of common shares outstanding, basic (In Shares)	1,536,474	1,323,659
Weighted average number of common shares outstanding, diluted (In Shares)	1,536,474	1,323,659